Sorafenib suppresses the epithelial-mesenchymal transition of hepatocellular carcinoma cells after insufficient radiofrequency ablation

BACKGROUND: Epithelial-mesenchymal transition (EMT) played an important role in the progression of hepatocellular carcinoma (HCC) after insufficient radiofrequency ablation (RFA). However, whether sorafenib could be used to suppress the EMT of HCC after insufficient RFA and further prevent the progr...

Descripción completa

Detalles Bibliográficos
Autores principales: Dong, Shuying, Kong, Jian, Kong, Fandong, Kong, Jinge, Gao, Jun, Ji, Liang, Pan, Bing, Chen, Lian, Zheng, Lemin, Sun, Wenbing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4663721/
https://www.ncbi.nlm.nih.gov/pubmed/26620566
http://dx.doi.org/10.1186/s12885-015-1949-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4663721/
https://www.ncbi.nlm.nih.gov/pubmed/26620566
http://dx.doi.org/10.1186/s12885-015-1949-7

Ejemplares similares